Vera Imper's most recent trade in Cytek BioSciences Inc was a trade of 43,973 Restricted Stock Units done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytek BioSciences Inc | Vera Imper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 43,973 | 43,973 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Vera Imper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 23,809 | 23,809 | - | - | Director Stock Option (right to buy) | |
| Cytek BioSciences Inc | Vera Imper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 15,706 | 0 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Vera Imper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 15,706 | 15,706 | - | - | Common Stock | |
| Cytek BioSciences Inc | Vera Imper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 23,076 | 23,076 | - | - | Stock Option (right to buy) | |
| Cytek BioSciences Inc | Vera Imper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 15,706 | 15,706 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Vera Imper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 30,242 | 30,242 | - | - | Stock Option (right to buy) | |
| Cytek BioSciences Inc | Vera Imper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 25,789 | 25,789 | - | - | Stock Option (right to buy) |